Remove 2016 Remove Organic Chemistry Remove Regulations Remove Treatment
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

These therapies have broadened treatment options for patients to expand beyond the more traditional small molecule drug alternatives. ADCs have the potential to redress the poor balance between safety and efficacy seen with traditional cancer treatment options.

article thumbnail

Could NfL accelerate drug development for neurodegenerative diseases?

Drug Discovery World

Interest in neurodegeneration amongst the public has increased in recent months due to several high-profile cases including rugby player Doddy Weir, who was diagnosed with motor neurone disease (MND) in 2016, and actor Bruce Willis, who was diagnosed with frontotemporal dementia (FTD) earlier this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Chemical Thank You PFAS regulation in California (late 2023 edition)

Agency IQ

PFAS regulation in California (late 2023 edition) California consistently maintains its status as both one of the most important economies in the world as well as one of the most regulated states in the United States. In 2019, the state began to significantly ramp up its PFAS regulation and research.

article thumbnail

How to Get Drugs Into the Brain

Drug Hunter

The BBB is composed of specialized brain endothelial cells that regulate the distribution of molecules into and out of the brain from the blood. Unlike the endothelial BBB, the blood-cerebrospinal fluid-barrier (BCSFB) is made up of epithelial cells that similarly regulate the distribution of molecules between the blood and CSF.

Drugs 206